With nationally known urologic oncologists and surgeons, UVA prostate cancer patients get top-level care from a ‘SEAL team’ of specialists.
Category: Oncology Innovations (Page 5)
UVA researchers are evaluating a novel CAR T-cell in order to expand this therapy to treat patients with untreatable lymphomas.
Racial disparities in colon cancer rates occur due to how the colon's different sides age. Current research analyzes why.
UVA research into treating deadly glioblastomas has found an oncogene to target and a way to use focused ultrasound never before possible.
In the journal Nature Communications, UVA Cancer Center researchers reveal a new mechanism for how androgen regulates communication within prostate cancer cells.